A Randomized, Double‐Blind, Placebo‐Controlled Trial of Combined Nevirapine and Zidovudine Compared with Nevirapine Alone in the Prevention of Perinatal Transmission of HIV in Zimbabwe
Paul Thistle(University of Toronto), Michael Silverman(Lakeridge Health), Richard H. Glazier(St. Michael's Hospital), Gordon Arbess, Maureen Gottesman(University of Toronto), Inam Chitsike, Andrew E. Simor(Sunnybrook Health Science Centre), Rachel F. Spitzer(University of Toronto), Tsungai Chipato(University of Zimbabwe-University of California San Francisco), Richard Pilon(Public Health Agency of Canada), Eleanor Boyle(Indiana University Northwest)
Cited by 23
Related Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
|New England Journal of Medicine|2018|1.2k
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
|Critical Care Medicine|2004|921
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
|Nature Medicine|2023|446
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348
Risk of Vertebrobasilar Stroke and Chiropractic Care
|Spine|2008|285